Zobrazeno 1 - 10
of 134
pro vyhledávání: '"M, Schurink"'
Autor:
Tessa M. Schurink‐van ’t Klooster, Albert G. Siebers, Joske Hoes, Folkert J. vanKemenade, Johannes Berkhof, Johannes A. Bogaards, Hester E. deMelker
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11786-11794 (2023)
Abstract Background The first HPV‐vaccine eligible cohorts in the Netherlands will enter the cervical screening program in 2023. However, a substantial number of young women already have had a cervical sample taken before entry into the regular scr
Externí odkaz:
https://doaj.org/article/0493e70b23d14ab59d97e807604f0375
Autor:
A. C. de Munter, T. M. Schurink-van t Klooster, A. van Lier, R. Akkermans, H. E. de Melker, W. L. M. Ruijs
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background In the Netherlands, the HPV-vaccine uptake was 52% during the 2009 catch-up campaign (birth cohorts 1993–1996). This increased to 61% in the regular immunization program (birth cohorts 2000–2001). However for birth cohorts 200
Externí odkaz:
https://doaj.org/article/402bbdb810d34e299340b7b2cdaf8f6f
Autor:
Klooster, Tessa M. Schurink-van 't1 tessa.schurink@rivm.nl, Siebers, Albert G.2, Hoes, Joske1, van Kemenade, Folkert J.3, Berkhof, Johannes4, Bogaards, Johannes A.1,4, de Melker, Hester E.1
Publikováno v:
Cancer Medicine. May2023, Vol. 12 Issue 10, p11786-11794. 9p.
Autor:
J. Hoes, H. Pasmans, T. M. Schurink-van ’t Klooster, F. R. M. van der Klis, R. Donken, J. Berkhof, H. E. de Melker
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
The licensed HPV vaccines are highly efficacious and induce high levels of neutralizing antibody levels, the assumed mediators of protection. However, a correlate of protection against HPV is lacking, and the evidence is still limited as to long-term
Externí odkaz:
https://doaj.org/article/19c32f9d89a746358a74f00be06b5cca
Autor:
René M H Wijnen, Maarten Schurink, Nagarajan Muthialu, Pietro Bagolan, Nazan Cobanoglu, Dhanya Mullassery, Holger Till, M. Singh, M. Boon, Sergei Hermelijn, Casper Kersten, Silvia Gartner, Carmen Mesas Burgos, Alberto Sgro, Stijn Heyman, Janne Suominen, Liesbeth Desender, Paul Losty, Kjetil Ertresvag, Harm A W M Tiddens, Marco Schnater, S.M. Hermelijn, C.M. Kersten, J.M. Schnater, R.M.H. Wijnen, H.A.W.M. Tiddens, S.C.M. Cochius, J. Suominen, M. Pakarinen, L. Martelius, S. Heyman, D. Vervloessem, H. Steyaert, A. Sgrò, P. Gamba, M. Schurink, S. van der Heide, J. Roukema, N. Rikkers-Mutsaerts, S. Terheggen-Lagro, S. de Beer, E. Haarman, H. Till, G. Singer, M. Metzelder, P Sezen, L. Desender, H. Schaballie, N. Cobanoglu, G. Gollu, M. Stanton, A. Bonnard, R. Sfeir, N. Muthialu, D. Mullassery, C. Wallis, D. Cox, P. Bagolan, F. Morini, C. Mesas Burgos, P. Conner, E. Caffrey Osvald, C. Bitkover, H. Decaluwé, M. Proesmans, J. Deprest, S. Gartner, A. Lain, P.D. Losty, I. Sinha, I. Yardley, L. Wessel, K. Zahn, T. Schaible, N. Qvist, M. Zampoli, G. Aksnes, C. K. van der Ent, K.M. Winter-de Groot, R. Peters, E. Hannon, Q. Jöbsis, M. Bannier
Publikováno v:
BMJ Open, Vol 11, Iss 4 (2021)
Introduction A worldwide lack of consensus exists on the optimal management of asymptomatic congenital pulmonary airway malformation (CPAM) even though the incidence is increasing. Either a surgical resection is performed or a wait-and-see policy is
Externí odkaz:
https://doaj.org/article/06c9a7aad0b64236b2f683b76fbd709b
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 12, Pp 1093-1104 (2018)
Introduction: Girls-only vaccination against human papillomavirus (HPV) type 16 and 18 was implemented in the Netherlands in 2009. Despite the evidence of the efficacy against precancerous lesions, cross-protection induced by the vaccine and a greate
Externí odkaz:
https://doaj.org/article/445ae3e7f6564acd9d4a08abf8a46a5b
Autor:
de Munter, A. C.1,2,3, Klooster, T. M. Schurink-van t4 tessa.schurink@rivm.nl, van Lier, A.4, Akkermans, R.2,5, de Melker, H. E.4, Ruijs, W. L. M.1,4
Publikováno v:
BMC Public Health. 10/12/2021, Vol. 21 Issue 1, p1-13. 13p. 1 Black and White Photograph, 3 Charts.
Autor:
Joske Hoes, Audrey J. King, Hester E. de Melker, Johannes Berkhof, Tessa M Schurink-van 't Klooster, Johannes A. Bogaards
Publikováno v:
Journal of Infectious Diseases. Oxford University Press
The Journal of infectious diseases, 226(4), 634-643. Oxford University Press
Hoes, J, King, A J, Klooster, T M S V, Berkhof, J, Bogaards, J A & de Melker, H E 2022, ' Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine : Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule ', The Journal of infectious diseases, vol. 226, no. 4, pp. 634-643 . https://doi.org/10.1093/infdis/jiab250, https://doi.org/10.1093/infdis/jiab250
The Journal of infectious diseases, 226(4), 634-643. Oxford University Press
Hoes, J, King, A J, Klooster, T M S V, Berkhof, J, Bogaards, J A & de Melker, H E 2022, ' Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine : Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule ', The Journal of infectious diseases, vol. 226, no. 4, pp. 634-643 . https://doi.org/10.1093/infdis/jiab250, https://doi.org/10.1093/infdis/jiab250
Background In the Netherlands, the bivalent human papillomavirus (HPV) vaccine has been offered to preadolescent girls via the National Immunization Program in a 2-dose schedule since 2014. The current study estimates vaccine effectiveness (VE) again
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f15eeca49b6a28b7186b4809b2c3ee2a
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85136745203&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85136745203&origin=inward
Autor:
A. R. Wahadat, W. Tanis, T. W. Galema, L. E. Swart, W. J. van Leeuwen, N. J. Verkaik, C. A. M. Schurink, B. van Dalen, S. Zoet-Nugteren, C. Gurlek, R. P. J. Budde, J. W. Roos-Hesselink
Publikováno v:
Netherlands Heart Journal, 31(1), 29-35. Bohn Stafleu van Loghum
Background In their latest guidelines for infective endocarditis (IE) (2015), the European Society of Cardiology (ESC) introduced the implementation of the Endocarditis Team (ET) to facilitate the management of IE. This study presents our experiences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ded1fab695ce85acaf628bad96c6da9
https://doi.org/10.1007/s12471-022-01707-6
https://doi.org/10.1007/s12471-022-01707-6
Autor:
Henrieke A. B. Prins, Raquel Crespo, Cynthia Lungu, Shringar Rao, Letao Li, Ronald J. Overmars, Grigorius Papageorgiou, Yvonne M. Mueller, Mateusz Stoszko, Tanvir Hossain, Tsung Wai Kan, Bart J. A. Rijnders, Hannelore I. Bax, Eric C. M. van Gorp, Jan L. Nouwen, Theodora E. M. S. de Vries-Sluijs, Carolina A. M. Schurink, Mariana de Mendonça Melo, Els van Nood, Angela Colbers, David Burger, Robert-Jan Palstra, Jeroen J. A. van Kampen, David A. M. C. van de Vijver, Thibault Mesplède, Peter D. Katsikis, Rob A. Gruters, Birgit C. P. Koch, Annelies Verbon, Tokameh Mahmoudi, Casper Rokx
Publikováno v:
Science Advances, 9
Science Advances, 9, 11
Science advances, 9(11):eade6675. American Association for the Advancement of Science
Science Advances, 9, 11
Science advances, 9(11):eade6675. American Association for the Advancement of Science
Contains fulltext : 291084.pdf (Publisher’s version ) (Open Access) Reactivation of the latent HIV-1 reservoir is a first step toward triggering reservoir decay. Here, we investigated the impact of the BAF complex inhibitor pyrimethamine on the res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c3887f3da1a82107e3f551dccee2edb
https://doi.org/10.1126/sciadv.ade6675
https://doi.org/10.1126/sciadv.ade6675